Pulmonary function tests in an infant with osteogenesis imperfecta and early biphosphonate treatment [3]

Acta Paediatrica, International Journal of Paediatrics

Volumn 96, Issue 12, 2007, Pages 1856-1857

  Rugolotto, S ^a,b   Monti, E ^a   Carli, M ^a   Pietrobelli, A ^a   Antoniazzi, F ^a   Tato', L ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b Clinica Pediatrica   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; NERIDRONIC ACID;

CASE REPORT; DISEASE SEVERITY; FEMALE; FRACTURE; HUMAN; INFANT; LETTER; LUNG FUNCTION TEST; NUCLEOTIDE SEQUENCE; OSTEOGENESIS IMPERFECTA; PEDIATRICS; POINT MUTATION; PRENATAL DEVELOPMENT; PRENATAL DISORDER; PRIORITY JOURNAL; PROGNOSIS; RADIODIAGNOSIS; RESPIRATORY FAILURE; SCOLIOSIS; THERAPY EFFECT;

BONE DENSITY CONSERVATION AGENTS; DIPHOSPHONATES; FATAL OUTCOME; FEMALE; HUMANS; INFANT; OSTEOGENESIS IMPERFECTA; POINT MUTATION; RESPIRATORY FUNCTION TESTS; RESPIRATORY INSUFFICIENCY;

EID: 36248936623     PISSN: 08035253     EISSN: 16512227     Source Type: Journal    
DOI: 10.1111/j.1651-2227.2007.00561.x     Document Type: Letter

References (5)

1. Rauch F, Glorieux FH. Osteogenesis imperfecta. Lancet 2004 363 : 1377 85.
2. McAllion S, Paterson C. Causes of death in osteogenesis imperfecta. J Clin Pathol 1996 49 : 627 30.
3. Falvo KA, Klain DB, Krauss AN, Root L, Auld PA. Pulmonary function studies in osteogenesis imperfecta. Am Rev Respir Dis 1973 108 : 1258 60.
4. Antoniazzi F, Zamboni G, Lauriola S, Donadi L, Adami S, Tato L. Early biphosphonate treatment in infants with severe osteogenesis imperfecta. J Pediatr 2006 149 : 174 9.
5. DiMeglio LA, Ford L, McClintock C, Peacock M. Intravenous pamidronate treatment of children under 36 months of age with osteogenesis imperfecta. Bone 2004 35 : 1038 45.